Evaluation of Prediction Accuracy for Volume of Distribution in Rat and Human Using In Vitro,In Vivo,PBPK and QSAR Methods |
| |
Authors: | Shibin Mathew David Tess Woodrow Burchett George Chang Nathaniel Woody Christopher Keefer Christine Orozco Jian Lin Samantha Jordan Shinji Yamazaki Rhys Jones Li Di |
| |
Affiliation: | 1. Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA;2. Early Clinical Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA;3. Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Groton, CT 06340, USA;4. Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, San Diego, CA 92121, USA |
| |
Abstract: | Volume of distribution at steady state (Vss) is an important pharmacokinetic parameter of a drug candidate. In this study, Vss prediction accuracy was evaluated by using: (1) seven methods for rat with 56 compounds, (2) four methods for human with 1276 compounds, and (3) four in vivo methods and three Kp (partition coefficient) scalar methods from scaling of three preclinical species with 125 compounds. The results showed that the global QSAR models outperformed the PBPK methods. Tissue fraction unbound (fu,t) method with adipose and muscle also provided high Vss prediction accuracy. Overall, the high performing methods for human Vss prediction are the global QSAR models, Øie-Tozer and equivalency methods from scaling of preclinical species, as well as PBPK methods with Kp scalar from preclinical species. Certain input parameter ranges rendered PBPK models inaccurate due to mass balance issues. These were addressed using appropriate theoretical limit checks. Prediction accuracy of tissue Kp were also examined. The fu,t method predicted Kp values more accurately than the PBPK methods for adipose, heart and muscle. All the methods overpredicted brain Kp and underpredicted liver Kp due to transporter effects. Successful Vss prediction involves strategic integration of in silico, in vitro and in vivo approaches. |
| |
Keywords: | Distribution Physiologically based pharmacokinetic (PBPK) modeling Quantitative structure–activity relationship(s) (QSAR) Absorption, distribution, metabolism, and excretion (ADME) Pharmacokinetics Protein binding Tissue partition Log partition coefficient (s) (log P/log PC) Partition coefficient(s) Interspecies (dose) scaling AAFE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" absolute average fold error AFE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" average fold error AUC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" area under the curve AUMC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" area under the first moment curve Bcrp" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" breast cancer resistance protein BW" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" body weight DMSO" },{" #name" :" keyword" ," $" :{" id" :" kwrd0145" }," $$" :[{" #name" :" text" ," _" :" dimethyl sulfoxide ELogD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0165" }," $$" :[{" #name" :" text" ," _" :" a reverse phase chromatographic method for measurement of LogD GBM" },{" #name" :" keyword" ," $" :{" id" :" kwrd0235" }," $$" :[{" #name" :" text" ," _" :" gradient boosting machine IV" },{" #name" :" keyword" ," $" :{" id" :" kwrd0255" }," $$" :[{" #name" :" text" ," _" :" intravenous LC-MS/MS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0295" }," $$" :[{" #name" :" text" ," _" :" liquid chromatography tandem mass spectrometry LogD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0305" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" Log" },{" #name" :" inf" ," $" :{" loc" :" post" }," _" :" 10" },{" #name" :" __text__" ," _" :" of distribution coefficient LogP" },{" #name" :" keyword" ," $" :{" id" :" kwrd0325" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" Log" },{" #name" :" inf" ," $" :{" loc" :" post" }," _" :" 10" },{" #name" :" __text__" ," _" :" of partition coefficient NCA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0335" }," $$" :[{" #name" :" text" ," _" :" noncompartmental analysis NL" },{" #name" :" keyword" ," $" :{" id" :" kwrd0345" }," $$" :[{" #name" :" text" ," _" :" neutral lipids NP" },{" #name" :" keyword" ," $" :{" id" :" kwrd0355" }," $$" :[{" #name" :" text" ," _" :" neutral phospholipids Oatps" },{" #name" :" keyword" ," $" :{" id" :" kwrd0365" }," $$" :[{" #name" :" text" ," _" :" organic anion transporting polypeptides PBPK" },{" #name" :" keyword" ," $" :{" id" :" kwrd0375" }," $$" :[{" #name" :" text" ," _" :" physiologically based pharmacokinetic PEG400" },{" #name" :" keyword" ," $" :{" id" :" kwrd0385" }," $$" :[{" #name" :" text" ," _" :" polyethylene glycol 400 P-gp" },{" #name" :" keyword" ," $" :{" id" :" kwrd0395" }," $$" :[{" #name" :" text" ," _" :" P-glycoprotein PK" },{" #name" :" keyword" ," $" :{" id" :" kwrd0405" }," $$" :[{" #name" :" text" ," _" :" pharmacokinetics PR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0425" }," $$" :[{" #name" :" text" ," _" :" unknown protein species for mass balance QSAR" },{" #name" :" keyword" ," $" :{" id" :" kwrd0455" }," $$" :[{" #name" :" text" ," _" :" quantitative structure-activity relationship RBC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0465" }," $$" :[{" #name" :" text" ," _" :" red blood cell SF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0495" }," $$" :[{" #name" :" text" ," _" :" scaling factor SFLogD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0505" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" Log" },{" #name" :" inf" ," $" :{" loc" :" post" }," _" :" 10" },{" #name" :" __text__" ," _" :" of distribution coefficient by shake-flask method |
本文献已被 ScienceDirect 等数据库收录! |
|